Home Cart 0 Sign in  
X

[ CAS No. 120363-13-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 120363-13-5
Chemical Structure| 120363-13-5
Chemical Structure| 120363-13-5
Structure of 120363-13-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 120363-13-5 ]

Related Doc. of [ 120363-13-5 ]

Alternatived Products of [ 120363-13-5 ]

Product Details of [ 120363-13-5 ]

CAS No. :120363-13-5 MDL No. :MFCD11501908
Formula : C11H13IO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QHHNHUWOOFETNQ-UHFFFAOYSA-N
M.W : 304.12 Pubchem ID :11130493
Synonyms :

Calculated chemistry of [ 120363-13-5 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 64.9
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.97
Log Po/w (XLOGP3) : 3.41
Log Po/w (WLOGP) : 3.25
Log Po/w (MLOGP) : 3.67
Log Po/w (SILICOS-IT) : 3.4
Consensus Log Po/w : 3.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.99
Solubility : 0.0309 mg/ml ; 0.000102 mol/l
Class : Soluble
Log S (Ali) : -3.64
Solubility : 0.0693 mg/ml ; 0.000228 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.23
Solubility : 0.0177 mg/ml ; 0.0000583 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.06

Safety of [ 120363-13-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 120363-13-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 120363-13-5 ]
  • Downstream synthetic route of [ 120363-13-5 ]

[ 120363-13-5 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 120363-13-5 ]
  • [ 774-65-2 ]
  • [ 58656-98-7 ]
Reference: [1] Chemistry - An Asian Journal, 2013, vol. 8, # 4, p. 705 - 708
  • 2
  • [ 619-58-9 ]
  • [ 865-47-4 ]
  • [ 120363-13-5 ]
YieldReaction ConditionsOperation in experiment
99.9%
Stage #1: at 75℃; for 1 h; Inert atmosphere
Stage #2: at 0℃; for 0.5 h;
Thionyl chloride (2.30 ml, 32.30 mmol) and N,N-dimethylformamide (DMF) (0.02 ml, 0.20 mmol) were added to 4-iodobenzoic acid (1.00 g, 4.00 mmol), and then the reaction system was substituted with nitrogen, heated to 75 °C, refluxed, and then stirred for 1 hour. The reaction solution was concentrated under reduced pressure, the obtained residue was dissolved in tetrahydrofuran (5 ml), and then a potassium tert-butoxide 1M solution in THF (4.5 ml) was slowly added at a sub-zero temperature, and stirred for 30 minutes. The reaction solution was concentrated under reduced pressure, and the obtained residue was diluted with ethyl acetate and washed with water and brine. An organic solvent layer was collected, dehydrated with anhydrous magnesium sulfate (MgSO4), filtered, and then concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography (Hex:EA=9:1), thereby obtaining 2-(trimethylsilyl)ethyl 4-iodobenzoate (14.00 g, 99.9percent yield). 1H NMR (CDCl3, 400 MHz) δ 7.77 (2H, d, J = 7.5 Hz, aromatic), 7.69 (2H, d, J = 8.0 Hz, aromatic), 1.59 (9H, s, (CH3)3).
Reference: [1] Patent: EP3327000, 2018, A1, . Location in patent: Paragraph 0116
[2] Bioconjugate Chemistry, 2015, vol. 26, # 2, p. 197 - 200
  • 3
  • [ 1711-02-0 ]
  • [ 75-65-0 ]
  • [ 120363-13-5 ]
YieldReaction ConditionsOperation in experiment
100% at 90℃; for 28 h; To a suspension of 4-iodobenzoic acid (2.00 g, 8.06 mmol) in toluene (16 mL)Thionyl chloride (4 mL) was added at room temperature, and the mixture was stirred under heating reflux for 2 hours.After returning the reaction solution to room temperature,By concentration under reduced pressure,A crude product of 4-iodobenzoyl chloride was obtained.Tert-Butyl alcohol (7.71 mL, 80.6 mmol) and 4- (dimethylamino) pyridine (99 mg, 0.806 mmol) were added at room temperature to a solution of crude 4-iodobenzoyl chloride in pyridine (16 mL)Followed by stirring at 90 ° C. for 28 hours.To the reaction solution was added a saturated aqueous sodium hydrogen carbonate solution at 0 ° C.,And extracted with ethyl acetate.The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.The resulting crude product was purified by column chromatography (hexane: ethyl acetate = 50: 1) to obtain a colorless oil of tert-butyl 4-iodobenzoate (2.45 g, yield: quantitative) .
Reference: [1] Patent: JP2015/848, 2015, A, . Location in patent: Paragraph 0215-0217
  • 4
  • [ 619-58-9 ]
  • [ 115-11-7 ]
  • [ 120363-13-5 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 24, p. 7947 - 7952
[2] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 7952 - 7966
[3] Patent: US2001/44535, 2001, A1,
  • 5
  • [ 619-58-9 ]
  • [ 36805-97-7 ]
  • [ 120363-13-5 ]
Reference: [1] Patent: WO2007/128817, 2007, A2, . Location in patent: Page/Page column 90
  • 6
  • [ 201230-82-2 ]
  • [ 540-37-4 ]
  • [ 75-65-0 ]
  • [ 120363-13-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 32, p. 6715 - 6719
  • 7
  • [ 75-91-2 ]
  • [ 51628-12-7 ]
  • [ 120363-13-5 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 104, p. 102023 - 102027
  • 8
  • [ 619-58-9 ]
  • [ 75-65-0 ]
  • [ 120363-13-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 415 - 420
  • 9
  • [ 619-58-9 ]
  • [ 120363-13-5 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 10, p. 3585 - 3591
[2] Patent: JP2015/848, 2015, A,
  • 10
  • [ 865-47-4 ]
  • [ 1711-02-0 ]
  • [ 120363-13-5 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 10, p. 3585 - 3591
  • 11
  • [ 120363-13-5 ]
  • [ 111291-97-5 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 10, p. 3585 - 3591
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 120363-13-5 ]

Aryls

Chemical Structure| 173406-17-2

[ 173406-17-2 ]

tert-Butyl 3-iodobenzoate

Similarity: 0.98

Chemical Structure| 51934-41-9

[ 51934-41-9 ]

Ethyl 4-iodobenzoate

Similarity: 0.94

Chemical Structure| 136618-42-3

[ 136618-42-3 ]

Benzyl 4-iodobenzoate

Similarity: 0.94

Chemical Structure| 58313-23-8

[ 58313-23-8 ]

Ethyl-3-iodobenzoate

Similarity: 0.93

Chemical Structure| 619-44-3

[ 619-44-3 ]

Methyl 4-iodobenzoate

Similarity: 0.91

Esters

Chemical Structure| 173406-17-2

[ 173406-17-2 ]

tert-Butyl 3-iodobenzoate

Similarity: 0.98

Chemical Structure| 51934-41-9

[ 51934-41-9 ]

Ethyl 4-iodobenzoate

Similarity: 0.94

Chemical Structure| 136618-42-3

[ 136618-42-3 ]

Benzyl 4-iodobenzoate

Similarity: 0.94

Chemical Structure| 58313-23-8

[ 58313-23-8 ]

Ethyl-3-iodobenzoate

Similarity: 0.93

Chemical Structure| 619-44-3

[ 619-44-3 ]

Methyl 4-iodobenzoate

Similarity: 0.91